Drugs / PurApo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04846010 | Mar 2021 → May 2022 | bipolar depression, gastroesophageal reflux disease, glomerulonephritis, hepatitis +7 | All Natural Medicine Clinic, LLC | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PurApo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04846010 ↗ |